Ignite Creation Date:
2025-12-24 @ 12:12 PM
Ignite Modification Date:
2025-12-27 @ 10:43 PM
Study NCT ID:
NCT04676061
Status:
TERMINATED
Last Update Posted:
2024-02-02
First Post:
2020-12-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™
Sponsor:
Baylor Research Institute
Organization:
Study Overview
Official Title:
Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™; a Randomized Double-Blinded Placebo-Controlled Trial
Status:
TERMINATED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
It was in the best interest of the investigator to terminate the study earlier than anticipated.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Effects of norethindrone acetate (NTA) in patients with Nexplanon.
Detailed Description:
The purpose of this study is to find out what effects norethindrone acetate (NTA) has on the duration and recurrence of frequent and/or prolonged bleeding associated with Nexplanon™.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: